Human ferritin for tumor detection and therapy

Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology

Volumn 5, Issue 4, 2013, Pages 287-298

  Fan, Kelong ^a,b   Gao, Lizeng ^a   Yan, Xiyun ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN FERRITIN; IRON-STORAGE PROTEIN; LIVING ORGANISMS; MAGNETOFERRITIN; NOVEL FUNCTIONS; RECENT RESEARCHES; TRANSFERRIN RECEPTOR 1; TUMOR DETECTION;

BIOLOGY; BIOSYNTHESIS; BODY FLUIDS; IRON OXIDES; IRON RESEARCH; PROTEINS;

TUMORS;

CD71 ANTIGEN; DOXORUBICIN; FERRITIN; IRON OXIDE; MAGNETOFERRITIN; NANOPARTICLE; PEROXIDASE; TUMOR MARKER; UNCLASSIFIED DRUG;

ARTICLE; CATALYSIS; DRUG DELIVERY SYSTEM; FERRITIN BLOOD LEVEL; HUMAN; IRON STORAGE; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; SYNTHESIS;

APOFERRITINS; DRUG DELIVERY SYSTEMS; FERRITINS; HUMANS; IRON; IRON-BINDING PROTEINS; NEOPLASMS; OXIDES; RECEPTORS, CELL SURFACE; TUMOR MARKERS, BIOLOGICAL;

EID: 84879221316     PISSN: 19395116     EISSN: 19390041     Source Type: Journal    
DOI: 10.1002/wnan.1221     Document Type: Article

References (72)

1. Arosio P, Ingrassia R, Cavadini P. Ferritins: a family of molecules for iron storage, antioxidation and more. Biochim Biophys Acta 2009, 1790:589-599.
2. Theil EC. Ferritin - structure, gene-regulation, and cellular function in animals, plants, and microorganisms. Annu Rev Biochem 1987, 56:289-315.
3. Wang W, Knovich MA, Coffman LG, Torti FM, Torti SV. Serum ferritin: past, present and future. Biochim Biophys Acta 2010, 1800:760-769.
4. Harrison PM, Arosio P. The ferritins: molecular properties, iron storage function and cellular regulation. Biochim Biophys Acta 1996, 1275:161-203.
5. Meyron-Holtz EG, Moshe-Belizowski S, Cohen LA. A possible role for secreted ferritin in tissue iron distribution. J Neural Transm 2011, 118:337-347.
6. Knovich MA, Storey JA, Coffman LG, Torti SV, Torti FM. Ferritin for the clinician. Blood Rev 2009, 23:95-104.
7. Fan J, Yin JJ, Ning B, Wu X, Hu Y, Ferrari M, Anderson GJ, Wei J, Zhao Y, Nie G. Direct evidence for catalase and peroxidase activities of ferritin-platinum nanoparticles. Biomaterials 2011, 32:1611-1618.
8. Uchida M, Flenniken ML, Allen M, Willits DA, Crowley BE, Brumfield S, Willis AF, Jackiw L, Jutila M, Young MJ, et al. Targeting of cancer cells with ferrimagnetic ferritin cage nanoparticles. J Am Chem Soc 2006, 128:16626-16633.
9. Uchida M, Terashima M, Cunningham CH, Suzuki Y, Willits DA, Willis AF, Yang PC, Tsao PS, McConnell MV, Young MJ, et al. A human ferritin iron oxide nano-composite magnetic resonance contrast agent. Magn Reson Med 2008, 60:1073-1081.
10. Terashima M, Uchida M, Kosuge H, Tsao PS, Young MJ, Conolly SM, Douglas T, McConnell MV. Human ferritin cages for imaging vascular macrophages. Biomaterials 2011, 32:1430-1437.
11. Cao CQ, Tian LX, Liu QS, Liu WF, Chen GJ, Pan YX. Magnetic characterization of noninteracting, randomly oriented, nanometer-scale ferrimagnetic particles. J Geophy Res 2010, 115:B07103.
12. Li K, Zhang ZP, Luo M, Yu X, Han Y, Wei HP, Cui ZQ, Zhang XE. Multifunctional ferritin cage nanostructures for fluorescence and MR imaging of tumor cells. Nanoscale 2012, 4:188-193.
13. Li L, Fang CJ, Ryan JC, Niemi EC, Lebron JA, Bjorkman PJ, Arase H, Torti FM, Torti SV, Nakamura MC, et al. Binding and uptake of H-ferritin are mediated by human transferrin receptor-1. Proc Natl Acad Sci U S A 2010, 107:3505-3510.
14. Fan K, Cao C, Pan Y, Lu D, Yang D, Feng J, Song L, Liang M, Yan X. Magnetoferritin nanoparticles for targeting and visualizing tumour tissues. Nat Nanotechnol 2012, 7:459-464.
15. Torti FM, Torti SV. Regulation of ferritin genes and protein. Blood 2002, 99:3505-3516.
16. Santambrogio P, Levi S, Arosio P, Palagi L, Vecchio G, Lawson DM, Yewdall SJ, Artymiuk PJ, Harrison PM, Jappelli R, et al. Evidence that a salt bridge in the light chain contributes to the physical stability difference between heavy and light human ferritins. J Biol Chem 1992, 267:14077-14083.
17. Kang S, Oltrogge LM, Broomell CC, Liepold LO, Prevelige PE, Young M, Douglas T. Controlled assembly of bifunctional chimeric protein cages and composition analysis using noncovalent mass spectrometry. J Am Chem Soc 2008, 130:16527.
18. Uchida M, Kang S, Reichhardt C, Harlen K, Douglas T. The ferritin superfamily: supramolecular templates for materials synthesis. Biochim Biophys Acta 2010, 1800:834-845.
19. Elliott RL, Elliott MC, Wang F, Head JF. Breast-carcinoma and the role of iron-metabolism - a cytochemical, tissue-culture, and ultrastructural-study. Ann N Y Acad Sci 1993, 698:159-166.
20. Weinstein RE, Bond BH, Silberberg BK, Vaughn CB, Subbaiah P, Pieper DR. Tissue ferritin concentration and prognosis in carcinoma of the breast. Breast Cancer Res Treat 1989, 14:349-353.
21. Werneke D, Elliott R, Ledford L. The significance of increased tissue ferritin concentration in breast-carcinoma. Clin Chem 1990, 36:1062-1063.
22. Ryser H, Caulfield JB, Aub JC. Studies on protein uptake by isolated tumor cells. I. Electron microscopic evidence of ferritin uptake by Ehrlich ascites tumor cells. J Cell Biol 1962, 14:255-268.
23. Caulfield JB. Studies on ferritin uptake by isolated tumor cells. Lab Invest 1963, 12:1018-1025.
24. Easty GC, Yarnell MM, Andrews RD. The uptake of proteins by normal and tumour cells in vitro. Br J Cancer 1964, 18:354-367.
25. Fargion S, Arosio P, Fracanzani AL, Cislaghi V, Levi S, Cozzi A, Piperno A, Fiorelli G. Characteristics and expression of binding sites specific for ferritin H-chain on human cell lines. Blood 1988, 71:753-757.
26. Chen TT, Li L, Chung DH, Allen CD, Torti SV, Torti FM, Cyster JG, Chen CY, Brodsky FM, Niemi EC, et al. TIM-2 is expressed on B cells and in liver and kidney and is a receptor for H-ferritin endocytosis. J Exp Med 2005, 202:955-965.
27. Daniels TR, Delgado T, Rodriguez JA, Helguera G, Penichet ML. The transferrin receptor part I: biology and targeting with cytotoxic antibodies for the treatment of cancer. Clin Immunol 2006, 121:144-158.
28. Neckers LM, Trepel JB. Transferrin receptor expression and the control of cell growth. Cancer Invest 1986, 4:461-470.
29. O'Donnell KA, Yu D, Zeller KI, Kim JW, Racke F, Thomas-Tikhonenko A, Dang CV. Activation of transferrin receptor 1 by c-Myc enhances cellular proliferation and tumorigenesis. Mol Cell Biol 2006, 26:2373-2386.
30. Daniels TR, Delgado T, Helguera G, Penichet ML. The transferrin receptor part II: targeted delivery of therapeutic agents into cancer cells. Clin Immunol 2006, 121:159-176.
31. Daniels TR, Bernabeu E, Rodriguez JA, Patel S, Kozman M, Chiappetta DA, Holler E, Ljubimova JY, Helguera G, Penichet ML. The transferrin receptor and the targeted delivery of therapeutic agents against cancer. Biochim Biophys Acta 2012, 1820:291-317.
32. Laske DW, Youle RJ, Oldfield EH. Tumor regression with regional distribution of the targeted toxin TF-CRM107 in patients with malignant brain tumors. Nat Med 1997, 3:1362-1368.
33. Weaver M, Laske DW. Transferrin receptor ligand-targeted toxin conjugate (Tf-CRM107) for therapy of malignant gliomas. J Neurooncol 2003, 65:3-13.
34. Yang DC, Wang F, Elliott RL, Head JF. Expression of transferrin receptor and ferritin H-chain mRNA are associated with clinical and histopathological prognostic indicators in breast cancer. Anticancer Res 2001, 21:541-549.
35. Habeshaw JA, Lister TA, Stansfeld AG, Greaves MF. Correlation of transferrin receptor expression with histological class and outcome in non-Hodgkin lymphoma. Lancet 1983, 1:498-501.
36. Das Gupta A, Shah VI. Correlation of transferrin receptor expression with histologic grade and immunophenotype in chronic lymphocytic leukemia and non-Hodgkin's lymphoma. Hematol Pathol 1990, 4:37-41.
37. Kondo K, Noguchi M, Mukai K, Matsuno Y, Sato Y, Shimosato Y, Monden Y. Transferrin receptor expression in adenocarcinoma of the lung as a histopathologic indicator of prognosis. Chest 1990, 97:1367-1371.
38. Seymour GJ, Walsh MD, Lavin MF, Strutton G, Gardiner RA. Transferrin receptor expression by human bladder transitional cell carcinomas. Urol Res 1987, 15:341-344.
39. Jezequel P, Campion L, Spyratos F, Loussouarn D, Campone M, Guerin-Charbonnel C, Joalland MP, Andre J, Descotes F, Grenot C, et al. Validation of tumor-associated macrophage ferritin light chain as a prognostic biomarker in node-negative breast cancer tumors: a multicentric 2004 national PHRC study. Int J Cancer 2012, 131:426-437.
40. Matzner Y, Konijn AM, Hershko C. Serum ferritin in hematologic malignancies. Am J Hematol 1980, 9:13-22.
41. Szymendera JJ, Kozlowiczgudzinska I, Madej G, Sikorowa L, Kaminska JA, Kowalska M. Clinical usefulness of serum ferritin measurements in patients with testicular germ-cell tumors. Oncology 1985, 42:253-258.
42. Volpino P, Cangemi V, Caputo V, Mazzarino E, Galati G. Clinical usefulness of serum ferritin measurements in lung-cancer patients. J Nucl Med Allied Sci 1984, 28:27-30.
43. Gray CP, Arosio P, Hersey P. Association of increased levels of heavy-chain ferritin with increased CD4+ CD25+ regulatory T-cell levels in patients with melanoma. Clin Cancer Res 2003, 9:2551-2559.
44. de Almeida SM, da Cunha DS, Yamada E, Doi EM, Ono M. Quantification of cerebrospinal fluid ferritin as a biomarker for Cns malignant infiltration. Arq Neuro-psiquiat 2008, 66:720-724.
45. Carpagnano GE, Lacedonia D, Palladino GP, Koutelou A, Martinelli D, Orlando S, Foschino-Barbaro MP. Could exhaled ferritin and SOD be used as markers for lung cancer and prognosis prediction purposes? Eur J Clin Invest 2012, 42:478-486.
46. Cazzola M, Arosio P, Bellotti V, Bergamaschi G, Dezza L, Iacobello C, Ruggeri G, Zappone E, Albertini A, Ascari E. Immunological reactivity of serum ferritin in patients with malignancy. Tumori 1985, 71:547-554.
47. Sun CJ, Yang H, Yuan Y, Tian X, Wang LM, Guo Y, Xu L, Lei JL, Gao N, Anderson GJ, et al. Controlling assembly of paired gold clusters within apoferritin nanoreactor for in vivo kidney targeting and biomedical imaging. J Am Chem Soc 2011, 133:8617-8624.
48. Kashanian S, Tarighat FA, Rafipour R, Abbasi-Tarighat M. Biomimetic synthesis and characterization of cobalt nanoparticles using apoferritin, and investigation of direct electron transfer of Co(NPs)-ferritin at modified glassy carbon electrode to design a novel nanobiosensor. Mol Biol Rep 2012, 39:8793-8802.
49. Suzumoto Y, Okuda M, Yamashita I. Fabrication of zinc oxide semiconductor nanoparticles in the apoferritin cavity. Cryst Growth Design 2012, 12:4130-4134.
50. Meldrum FC, Wade VJ, Nimmo DL, Heywood BR, Mann S. Synthesis of inorganic nanophase materials in supramolecular protein cages. Nature 1991, 349:684-687.
51. Meldrum FC, Heywood BR, Mann S. Magnetoferritin: in vitro synthesis of a novel magnetic protein. Science 1992, 257:522-523.
52. Dreher MR, Liu WG, Michelich CR, Dewhirst MW, Yuan F, Chilkoti A. Tumor vascular permeability, accumulation, and penetration of macromolecular drug carriers. J Natl Cancer Inst 2006, 98:335-344.
53. Gao L, Zhuang J, Nie L, Zhang J, Zhang Y, Gu N, Wang T, Feng J, Yang D, Perrett S, et al. Intrinsic peroxidase-like activity of ferromagnetic nanoparticles. Nat Nanotechnol 2007, 2:577-583.
54. Kitagawa T, Kosuge H, Uchida M, Dua MM, Iida Y, Dalman RL, Douglas T, McConnell MV. RGD-conjugated human ferritin nanoparticles for imaging vascular inflammation and angiogenesis in experimental carotid and aortic disease. Mol Imaging Biol 2012, 14:315-324.
55. Lin X, Xie J, Niu G, Zhang F, Gao H, Yang M, Quan Q, Aronova MA, Zhang G, Lee S, et al. Chimeric ferritin nanocages for multiple function loading and multimodal imaging. Nano Lett 2011, 11:814-819.
56. Lee S, Lin X, Xie J, Zhu L, Niu G, Ma Y, Kim K, Chen XY. Hybrid ferritin nanoparticles as activatable probes for tumor imaging. Angew Chem Int Ed Engl 2011, 50:1569-1572.
57. Vannucci L, Falvo E, Fornara M, Di Micco P, Benada O, Krizan J, Svoboda J, Hulikova-Capkova K, Morea V, Boffi A, et al. Selective targeting of melanoma by PEG-masked protein-based multifunctional nanoparticles. Int J Nanomed 2012, 7:1489-1509.
58. Li X, Qiu LH, Zhu P, Tao XY, Imanaka T, Zhao J, Huang YG, Tu YP, Cao XN. Epidermal growth factor-ferritin h-chain protein nanoparticles for tumor active targeting. Small 2012, 8:2505-2514.
59. Kang HJ, Kang YJ, Lee YM, Shin HH, Chung SJ, Kang S. Developing an antibody-binding protein cage as a molecular recognition drug modular nanoplatform. Biomaterials 2012, 33:5423-5430.
60. Aime S, Frullano L, Crich SG. Compartmentalization of a gadolinium complex in the apoferritin cavity: A route to obtain high relaxivity contrast agents for magnetic resonance imaging. Angew Chem Int Ed Engl 2002, 41:1017.
61. Crich SG, Bussolati B, Tei L, Grange C, Esposito G, Lanzardo S, Camussi G, Aime S. Magnetic resonance visualization of tumor angiogenesis by targeting neural cell adhesion molecules with the highly sensitive gadolinium-loaded apoferritin probe. Cancer Res 2006, 66:9196-9201.
62. Gilad AA, Winnard PT, van Zijl PCM, Bulte JWM. Developing MR reporter genes: promises and pitfalls. Nmr Biomed 2007, 20:275-290.
63. Cohen B, Ziv K, Plaks V, Harmelin A, Neeman M. Ferritin nanoparticles as magnetic resonance reporter gene. WIREs: Nanomed Nanobiotechnol 2009, 1: 181-188.
64. Kim HS, Cho HR, Choi SH, Woo JS, Moon WK. In vivo imaging of tumor transduced with bimodal lentiviral vector encoding human ferritin and green fluorescent protein on a 1.5T clinical magnetic resonance scanner. Cancer Res 2010, 70:7315-7324.
65. Choi SH, Cho HR, Kim HS, Kim YH, Kang KW, Kim H, Moon WK. Imaging and quantification of metastatic melanoma cells in lymph nodes with a ferritin MR reporter in living mice. NMR Biomed 2012, 25:737-745.
66. Naumova AV, Reinecke H, Yarnykh V, Deem J, Yuan C, Murry CE. Ferritin overexpression for noninvasive magnetic resonance imaging-based tracking of stem cells transplanted into the heart. Mol Imaging 2010, 9:201-210.
67. Campan M, Lionetti V, Aquaro GD, Forini F, Matteucci M, Vannucci L, Chiuppesi F, Di Cristofano C, Faggioni M, Maioli M, et al. Ferritin as a reporter gene for in vivo tracking of stem cells by 1.5-T cardiac MRI in a rat model of myocardial infarction. Am J Physiol Heart Circ Physiol 2011, 300:H2238-H2250.
68. Li JY, Paragas N, Ned RM, Qiu A, Viltard M, Leete T, Drexler IR, Chen X, Sanna-Cherchi S, Mohammed F, et al. Scara5 is a ferritin receptor mediating non-transferrin iron delivery. Dev Cell 2009, 16: 35-46.
69. Kilic MA, Ozlu E, Calis S. A novel protein-based anticancer drug encapsulating nanosphere: apoferritin-doxorubicin complex. J Biomed Nanotechnol 2012, 8:508-514.
70. Simsek E, Kilic MA. Magic ferritin: a novel chemotherapeutic encapsulation bullet. J Magn Magn Mater 2005, 293:509-513.
71. Ji XT, Huang L, Huang HQ. Construction of nanometer cisplatin core-ferritin (NCC-F) and proteomic analysis of gastric cancer cell apoptosis induced with cisplatin released from the NCC-F. J Proteomics 2012, 75:3145-3157.
72. Dehal PK, Livingston CF, Dunn CG, Buick R, Luxton R, Pritchard DJ. Magnetizable antibody-like proteins. Biotechnol J 2010, 5:596-604.